ASCO 2022 Conference Coverage


 

ASCO 2022 MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab vs. Avelumab After 1L Platinum-Based Chemo in Pts With mUC (Alliance A032001)

722 views
June 14, 2022
Comments 0
Login to view comments. Click here to Login